BrioAlphaSIP is a SME Nanotechnology company, established in 2008, focused on the development of sensors based on carbon surfaces to develop pioneer techniques in the digital diagnostic area. AlphaSIP’s main goal is to design, develop and produce molecular diagnostic chips that allow immediate and effective illness detection, promoting better health care services for patients and great advances towards personalized medicine. The Company’s primary focus is on Haematology and Hemostasis segments, which have exponentially grown in the past decade, due to the increase in the number of individuals affected by Cardiovascular Diseases (CVD) and an ageing society. The overall aim of AlphaSIP’s R& D is to evaluate the expected impact of material innovation, equipment and advanced manufacturing processes and to drive health care towards personalized medicine.

Last modified 3 years ago Last modified on Oct 22, 2015, 8:39:07 AM